Abstract
Pulmonary lymphoepithelioma-like carcinoma (LELC) is a rare subtype of large cell carcinoma. We report a case of a 60-year-old male who presented with a left hilar mass. Initially detected as a 2 cm lesion, the tumor was monitored conservatively for four years due to its slow growth and lack of definitive malignant features on initial biopsy. Over 48 months, the tumor grew to 3.5 cm and caused recurrent obstructive pneumonia. Surgical intervention revealed extensive invasion of the pulmonary artery, necessitating a total left pneumonectomy. Pathological analysis confirmed LELC (Stage IIB, pT2N1M0), notably testing negative for Epstein-Barr virus (EBV). This case underscores the clinical challenges of managing slow-growing hilar masses and the potential for late-stage local invasion despite an indolent growth rate.
Introduction
Pulmonary Lymphoepithelioma-Like Carcinoma (LELC) is an uncommon variant of non-small cell lung cancer (NSCLC), histologically resembling undifferentiated nasopharyngeal carcinoma. While strongly associated with Epstein-Barr virus (EBV) in Southeast Asian populations, its characteristics in other regions are less defined. Due to its rarity, the natural clinical history of LELC is poorly documented, often leading to diagnostic delays or overly conservative management. This paper details a longitudinal observation of LELC progression over four years.
Case Presentation
A 60-year-old male was referred following the detection of an abnormal left hilar shadow on a routine chest X-ray. Initial CT imaging revealed a 2.0 cm round mass. Given the slow growth and inconclusive initial biopsies—likely due to the tumor's extramural location—the mass was monitored conservatively.
Over the next four years, the tumor exhibited a remarkably slow doubling time. However, by the 48-month mark, the mass had reached 3.5 cm, leading to worsening obstructive pneumonia and necessitating surgical intervention.
Surgical and Pathological Findings
Pre-operative staging was complicated by the tumor's proximity to major vascular structures. CT imaging was critical in identifying the mass's relationship with the pulmonary hilum and its potential for invasion.
During surgery, the tumor was found to have extensively invaded the main pulmonary artery. This necessitated a total left pneumonectomy rather than a more conservative sleeve resection. Pathological examination confirmed the diagnosis of LELC, Stage IIB (pT2N1M0). Interestingly, EBER in-situ hybridization was negative, indicating no association with EBV—a finding more common in Japanese and Western cohorts compared to endemic regions.
Discussion
This case highlights the "shrinkage trap" and the dangers of "watchful waiting" for hilar masses. Early in the observation period, the tumor appeared to decrease slightly in size (from 2.0 cm to 1.8 cm), which falsely reassured clinicians. Despite its slow growth, the central location of LELC means that even minor progression can lead to the invasion of vital structures like the pulmonary artery.
Standard transbronchial biopsies failed multiple times because the tumor was located outside the bronchial wall, highlighting the diagnostic difficulty of hilar LELC. While LELC generally carries a more favorable prognosis than other NSCLCs (with 5-year survival rates around 88%), this case demonstrates that surgical delay can significantly increase the morbidity of the required procedure, turning a potential lobectomy into a pneumonectomy.
Conclusion
Pulmonary LELC can present as an indolent hilar mass that mimics benign lymphadenopathy. Clinicians should maintain a high index of suspicion for malignancy in persistent hilar shadows, as the slow growth rate of LELC does not preclude aggressive local invasion. Early surgical intervention is paramount to avoid the need for extensive resections like pneumonectomy.
Summary updated